Akero Therapeutics (AKRO)
(Delayed Data from NSDQ)
$18.82 USD
+0.51 (2.79%)
Updated May 31, 2024 04:00 PM ET
After-Market: $18.85 +0.03 (0.16%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For AKRO
-
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Can Akero Therapeutics (AKRO) Run Higher on Strong Earnings Estimate Revisions?